• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Sweden·Healthcare·SECT-B.ST
Share

Sectra AB (publ) Stocks

SEK 336.2Last Updated 23.10.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

SEK 6.53B

SEK 336.2
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

06.03.2026 15:08

The week after the Iran war began could be the worst for EU stocks in almost a year

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Sectra AB (publ), a Swedish company established in Linköping in 1957, specializes in providing advanced information technology solutions for both the medical and cybersecurity fields. Its services are predominantly offered across Europe, including key markets such as Sweden, the United Kingdom, and the Netherlands. The company's operations are structured into three primary divisions: Imaging IT Solutions, Secure Communications, and Business Innovation. The Imaging IT Solutions segment is responsible for creating and deploying medical IT systems and support services. These offerings are designed to efficiently manage, archive, and present various types of medical images and patient data, while also facilitating operational oversight and monitoring radiation exposure. This division further provides comprehensive maintenance, encompassing technical assistance and system surveillance, alongside expert consulting for integration, system architecture, data migration, and strategic business growth. Through its Secure Communications segment, Sectra engineers and supplies robust products and services aimed at ensuring secure voice and data exchanges, thereby protecting vital IT infrastructure. Beyond bespoke project development, this unit offers in-depth security and threat assessments, coupled with monitoring services for critical control systems. Finally, the Business Innovation segment focuses on pioneering and commercializing IT systems specifically tailored for the planning and supervision of orthopedic surgical procedures, in addition to developing educational tools and products for medical research initiatives. Sectra's diverse clientele includes both public and private healthcare providers, ranging from individual hospitals to extensive clinic networks, as well as governmental organizations, national defense departments, and companies operating within the energy sector.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of SECT-B.ST is 346 and suggests 2.89% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommend

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.10.2026 22:15

Revolut has begun offering consumer loans in the U.K. What does this mean for the company?

26.10.2026 21:31

Tesla shares surged: Barclays advised buying them ahead of the merger with SpaceX

26.10.2026 21:09

"We Decided Not to Delay": What Analysts Are Saying About Anthropic's IPO Prospectus

26.10.2026 19:24

Investors Won't Share in the Profits, Risks, or Impact on the Workforce: Key Points About Anthropic's IPO

26.10.2026 19:13

Aardvark sinks 65% on data from halted trial of hunger drug; FDA to allow new tests

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026